Sonoma Pharmaceuticals Inc [SNOA] stock prices are up 40.20% to $2.79 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SNOA shares have gain 31.60% over the last week, with a monthly amount glided 5.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Sonoma Pharmaceuticals Inc [SNOA] has been fluctuating between $1.90 and $9.37 over the past year. Sonoma Pharmaceuticals Inc [NASDAQ: SNOA] shares were valued at $2.79 at the most recent close of the market.
Analyzing the SNOA fundamentals
The Sonoma Pharmaceuticals Inc [NASDAQ:SNOA] reported sales of 13.97M for trailing twelve months, representing a surge of 13.58%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.32%, Pretax Profit Margin comes in at -0.27%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.7 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.2400 points at the first support level, and at 1.6800 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.4400, and for the 2nd resistance point, it is at 4.0800.
Ratios To Look Out For
It’s worth pointing out that Sonoma Pharmaceuticals Inc [NASDAQ:SNOA]’s Current Ratio is 3.29. Further, the Quick Ratio stands at 2.44, while the Cash Ratio is 1.41. Considering the valuation of this stock, the price to sales ratio is 0.32, the price to book ratio is 0.93.
Transactions by insiders
Recent insider trading involved Gottfurcht Grant, 10% Owner, that happened on Jan 03 ’25 when 86111.0 shares were purchased. Open Market, Gottfurcht Grant completed a deal on Jan 02 ’25 to buy 30000.0 shares. Meanwhile, Open Market Purchase Gottfurcht Grant bought 17806.0 shares on Dec 31 ’24.
